<VariationArchive RecordType="classified" VariationID="464313" VariationName="NC_000022.11:g.(?_23787164)_(23834186_?)del" VariationType="Deletion" Accession="VCV000464313" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2017-12-26" MostRecentSubmission="2017-12-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="469839" VariationID="464313">
      <GeneList>
        <Gene Symbol="SMARCB1" FullName="SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1" GeneID="6598" HGNC_ID="HGNC:11103" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="23786966" stop="23838009" display_start="23786966" display_stop="23838009" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NT_187633.1" start="23328" stop="74371" display_start="23328" display_stop="74371" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="24129149" stop="24176704" display_start="24129149" display_stop="24176704" Strand="+" />
          </Location>
          <OMIM>601607</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMARCB1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMARCB1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000022.11:g.(?_23787164)_(23834186_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" innerStart="23787164" innerStop="23834186" display_start="23787164" display_stop="23834186" variantLength="47023" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" innerStart="24129351" innerStop="24176373" display_start="24129351" display_stop="24176373" variantLength="47023" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.(?_23787164)_(23834186_?)del" Assembly="GRCh38">
            <Expression>NC_000022.11:g.(?_23787164)_(23834186_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.(?_24129351)_(24176373_?)del" Assembly="GRCh37">
            <Expression>NC_000022.10:g.(?_24129351)_(24176373_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000022.11:g.(?_23787164)_(23834186_?)del AND Rhabdoid tumor predisposition syndrome 1" Accession="RCV000537984" Version="1">
        <ClassifiedConditionList TraitSetID="2181">
          <ClassifiedCondition DB="MedGen" ID="C1836327">Rhabdoid tumor predisposition syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-04-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-04-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-12-26" MostRecentSubmission="2017-12-26">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="2181" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5873" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rhabdoid tumor predisposition syndrome 1</ElementValue>
                <XRef ID="Rhabdoid+tumor+predisposition+syndrome+1/9251" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012252" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial Posterior Fossa Brain Tumor of Infancy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RTPS1</ElementValue>
                <XRef Type="MIM" ID="609322" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Rhabdoid tumor predisposition syndrome (RTPS) is characterized by a markedly increased risk of developing rhabdoid tumors â€“ rare and highly aggressive malignant tumors occurring predominantly in infants and children younger than age three years. Rhabdoid tumors can occur in almost any anatomic location, commonly in the central nervous system (i.e., atypical teratoid/rhabdoid tumor [AT/RT]); more than 50% occur in the cerebellum. Other common locations include extracranial extrarenal malignant rhabdoid tumors (e.g., rhabdoid tumors of the head and neck, paravertebral muscles, liver, bladder, mediastinum, retroperitoneum, pelvis, and heart) (eMRT), rhabdoid tumor of the kidney (RTK), and possibly small-cell carcinoma of the ovary (hypercalcemic type). Individuals with RTPS typically present before age 12 months with synchronous tumors that exhibit aggressive clinical behavior.</Attribute>
                <XRef ID="NBK469816" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29215836</ID>
                <ID Source="BookShelf">NBK469816</ID>
              </Citation>
              <XRef ID="231108" DB="Orphanet" />
              <XRef ID="69077" DB="Orphanet" />
              <XRef ID="C1836327" DB="MedGen" />
              <XRef ID="MONDO:0012252" DB="MONDO" />
              <XRef Type="MIM" ID="609322" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1231239" SubmissionDate="2017-10-05" DateLastUpdated="2017-12-26" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="1819902|MedGen:C1836327" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000638737" DateUpdated="2017-12-26" DateCreated="2017-12-26" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment Type="public">A gross deletion of the genomic region encompassing the full coding sequence of the SMARCB1 gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. Loss-of-function variants in SMARCB1 are known to be pathogenic. Deletions of the entire SMARCB1 gene, and the gross deletion of chr22q11 encompassing the SMARCB1 gene, have been reported in multiple individuals affected with rhabdoid tumor (PMID: 27092963, 24123847, 24933152, 23154773, 22814326, 21208904, 21412926). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMARCB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.10:g.(?_24129351)_(24176373_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1836327" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3109251</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1231239" TraitType="Disease" MappingType="XRef" MappingValue="C1836327" MappingRef="MedGen">
        <MedGen CUI="C1836327" Name="Rhabdoid tumor predisposition syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

